Common use of Transferability Clause in Contracts

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 208 contracts

Samples: Underwriting Agreement (RumbleON, Inc.), Securities Purchase Agreement (Microbot Medical Inc.), Underwriting Agreement (Catasys, Inc.)

AutoNDA by SimpleDocs

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 150 contracts

Samples: Common Stock Purchase (Innovus Pharmaceuticals, Inc.), Common Stock Purchase Warrant (Propanc Biopharma, Inc.), Common Stock Purchase (Pulmatrix, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 58 contracts

Samples: Underwriting Agreement (KWESST Micro Systems Inc.), Underwriting Agreement (OMNIQ Corp.), S Warrant Agreement (Marpai, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness Effective Date or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 35 contracts

Samples: Underwriting Agreement (Tapinator, Inc.), Underwriting Agreement (Bone Biologics Corp), Underwriting Agreement (Lixte Biotechnology Holdings, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(1)) and the Agreement, neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 28 contracts

Samples: Underwriting Agreement (Society Pass Incorporated.), Underwriting Agreement (Society Pass Incorporated.), Underwriting Agreement (Siyata Mobile Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 23 contracts

Samples: Locafy LTD, Digital Brands Group, Inc., Scilex Holding Co

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecatedhypothecated , or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 18 contracts

Samples: Aikido Pharma Inc., Check-Cap LTD, Check-Cap LTD

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares ADSs issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 13 contracts

Samples: Underwriting Agreement (Immuron LTD), Underwriting Agreement (SaverOne 2014 Ltd.), Underwriting Agreement (Immuron LTD)

Transferability. Pursuant to FINRA a) Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 11 contracts

Samples: Bio-Path Holdings Inc, Pain Therapeutics Inc, Neuralstem, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1)(A), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness Commencement Date or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 10 contracts

Samples: Underwriting Agreement (Twin Vee PowerCats, Co.), Underwriting Agreement (Twin Vee PowerCats, Co.), S Warrant Agreement (Zivo Bioscience, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issuedOffering, except the transfer of any security:

Appears in 9 contracts

Samples: Underwriting Agreement (BriaCell Therapeutics Corp.), Underwriting Agreement (BriaCell Therapeutics Corp.), Underwriting Agreement (Draganfly Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness Effective Date or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 9 contracts

Samples: Underwriting Agreement (NutriBand Inc.), Generation Income Properties, Inc., AmpliTech Group, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 7 contracts

Samples: Underwriting Agreement (Armlogi Holding Corp.), Underwriting Agreement (Armlogi Holding Corp.), Underwriting Agreement (Armlogi Holding Corp.)

Transferability. Pursuant to FINRA Rule 5110(g)(1)5110(e)(1) and the Agreement, neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 7 contracts

Samples: Underwriting Agreement (ARB IOT Group LTD), Underwriting Agreement (Cheetah Net Supply Chain Service Inc.), Underwriting Agreement (Cheetah Net Supply Chain Service Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1)(A), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 6 contracts

Samples: Underwriting Agreement (Ipsidy Inc.), Underwriting Agreement (Ipsidy Inc.), Underwriting Agreement (Harbor Custom Development, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(1)) and the Dealer Manager Agreement, neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days six (6) months immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 6 contracts

Samples: Hepion Pharmaceuticals, Inc., Sintx Technologies, Inc., Sintx Technologies, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1)(A), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 5 contracts

Samples: Underwriting Agreement (Innovation Beverage Group LTD), Underwriting Agreement (Innovation Beverage Group LTD), Flewber Global Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering Effective Date pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 5 contracts

Samples: Underwriting Agreement (Strong Global Entertainment, Inc), Underwriting Agreement (FG Group Holdings Inc.), Underwriting Agreement (Strong Global Entertainment, Inc)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares ADS issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 5 contracts

Samples: Kitov Pharma Ltd., Can-Fite BioPharma Ltd., Can-Fite BioPharma Ltd.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 5 contracts

Samples: Underwriting Agreement (Vallon Pharmaceuticals, Inc.), Underwriting Agreement (Vallon Pharmaceuticals, Inc.), Vallon Pharmaceuticals, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 5 contracts

Samples: Underwriting Agreement (RoyaLand Co Ltd.), Underwriting Agreement (RoyaLand Co Ltd.), Underwriting Agreement (Brera Holdings PLC)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1)(A), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering Commencement Date pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 4 contracts

Samples: Underwriting Agreement (SRM Entertainment, Inc.), Underwriting Agreement (EVmo, Inc.), EVmo, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred and eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering Effective Date pursuant to which this Warrant is being issued, except for the transfer of any security:security as provided in FINRA Rule 5110(e)(2).

Appears in 4 contracts

Samples: Underwriting Agreement (Ballantyne Strong, Inc.), S Warrant Agreement (Ballantyne Strong, Inc.), Underwriting Agreement (BK Technologies Corp)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 4 contracts

Samples: Antelope Enterprise Holdings LTD, Rocketfuel Blockchain, Inc., Mobiquity Technologies, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 4 contracts

Samples: Representative Warrant Agreement (Assure Holdings Corp.), T1V, Inc., Vision Marine Technologies Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities Securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering Securities in connection with the Offering pursuant to which this Warrant is being issued, except the transfer of any securityexcept:

Appears in 4 contracts

Samples: Common Stock Purchase Warrant (DatChat, Inc.), Common Stock Purchase (Grom Social Enterprises, Inc.), Common Stock Purchase Warrant (DatChat, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(1)) and the Underwriting Agreement, neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 3 contracts

Samples: Envision Solar International, Inc., Todos Medical Ltd., Envision Solar International, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares ADSs issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 3 contracts

Samples: Safe-T Group Ltd., Safe-T Group Ltd., Safe-T Group Ltd.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares Securities issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 360 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 3 contracts

Samples: Underwriting Agreement (Fat Brands, Inc), Underwriting Agreement (Fat Brands, Inc), Underwriting Agreement (Fat Brands, Inc)

Transferability. Pursuant to FINRA Rule 5110(g)(1)5110(e) and the Agreement, neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 3 contracts

Samples: Underwriting Agreement (Edible Garden AG Inc), Underwriting Agreement (Edible Garden AG Inc), Edible Garden AG Inc

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issuedEffective Date, except the transfer of any security:

Appears in 3 contracts

Samples: Underwriting Agreement (Sachem Capital Corp.), Underwriting Agreement (Sachem Capital Corp.), Underwriting Agreement (Sachem Capital Corp.)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares ADSs issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 3 contracts

Samples: Cellect Biotechnology Ltd., Can-Fite BioPharma Ltd., Cellect Biotechnology Ltd.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1)(A), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering Offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 3 contracts

Samples: Tivic Health Systems, Inc., Tivic Health Systems, Inc., Tivic Health Systems, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred and eighty (180) days immediately following beginning on the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Underwriting Agreement (HW Electro Co., Ltd.), Underwriting Agreement (HW Electro Co., Ltd.)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 360 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Esports Entertainment Group, Inc., Versus Systems Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Pingtan Marine Enterprise Ltd., Pingtan Marine Enterprise Ltd.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Intellipharmaceutics International Inc., Intellipharmaceutics International Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issuedSales Date, except the transfer of any security:

Appears in 2 contracts

Samples: Ocean Biomedical, Inc., Ocean Biomedical, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following beginning on the date of effectiveness or the commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Worksport LTD, Worksport LTD

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 360 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Creative Medical Technology Holdings, Inc., BioRestorative Therapies, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issuedCommencement Date, except the transfer of any security:

Appears in 2 contracts

Samples: Placement Agency Agreement (Biovie Inc.), Save Foods Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness the Underwriting Agreement or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: S Warrant Agreement (Gain Therapeutics, Inc.), Underwriting Agreement (XCel Brands, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days (with the understanding that the Holder has agreed to extend this period to one (1) year ) immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Inhibikase Therapeutics, Inc., Inhibikase Therapeutics, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness Qualification Date or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Purchase Common Stock (Level Brands, Inc.), Campagna Motors USA Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness Closing Date or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Data Storage Corp, Data Storage Corp

AutoNDA by SimpleDocs

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Underwriting Agreement (ProPhase Labs, Inc.), Inhibikase Therapeutics, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering Effective Date pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Underwriting Agreement (Flewber Global Inc.), Underwriting Agreement (Flewber Global Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:: ​

Appears in 2 contracts

Samples: Kiromic Biopharma, Inc., Kiromic Biopharma, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold during the Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness Effective Date or commencement of sales of the offering pursuant to which this Warrant is being issuedOffering (the “Lock-Up Period”), except the transfer of any securityexcept:

Appears in 2 contracts

Samples: Toughbuilt Industries, Inc, Toughbuilt Industries, Inc

Transferability. Pursuant to FINRA Rule 5110(g)(1)) and the Agreement, neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days 6 months immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: DelMar Pharmaceuticals, Inc., DelMar Pharmaceuticals, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person Person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Sushi Ginza Onodera, Inc., Silynxcom Ltd.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold during the Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issuedOffering (the “Lock-Up Period”), except the transfer of any securityexcept:

Appears in 2 contracts

Samples: Placement Agency Agreement (Akers Biosciences Inc), Akers Biosciences Inc

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares Securities issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Placement Agency Agreement (Pyxis Tankers Inc.), Pyxis Tankers Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness Effective Date or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 2 contracts

Samples: Inspira Technologies OXY B.H.N. LTD, Polyrizon Ltd.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: Bluejay Diagnostics, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: Versus Systems Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1)5110(e)(1) and the Agreement, neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issuedissued (the “Commencement Date”), except the transfer of any security:

Appears in 1 contract

Samples: Intrinsic Medicine, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:: ​

Appears in 1 contract

Samples: Common Stock Purchase (Assure Holdings Corp.)

Transferability. Pursuant to FINRA Rule 5110(g)(1)5110(e)(1) and the Agreement, neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the Common Stock in the Company’s initial public offering pursuant to which this Warrant is being issuedissued (the “Commencement Date”), except the transfer of any security:

Appears in 1 contract

Samples: Underwriting Agreement (Intrinsic Medicine, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering Commencement Date pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: Six15 Technologies Holding Corp.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness Closing Date or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: S Warrant Agreement (GeoVax Labs, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any ​ ​ hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:: ​

Appears in 1 contract

Samples: Common Stock Purchase (Assure Holdings Corp.)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:: Artelo - Form of Representative_s Warrant

Appears in 1 contract

Samples: Artelo Biosciences, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1)) and the Agreement, neither this Warrant nor any Warrant Shares ADSs issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days six (6) months immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: Underwriting Agreement (Intchains Group LTD)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issuedCommencement Date, except the transfer of any security:

Appears in 1 contract

Samples: Perfect Moment Ltd.

Transferability. Pursuant to FINRA Rule 5110(g)(1)) and the Agreement, neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days six (6) months immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: Underwriting Agreement (Ryde Group LTD)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1)(A), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness Effective Date or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: SIMPLICITY ESPORTS & GAMING Co

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following beginning on the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: Underwriting Agreement (Yoshitsu Co., LTD)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness the Purchase Agreement or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: Gain Therapeutics, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following beginning on the date of effectiveness or the commencement of sales of the offering Offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: Worksport LTD

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 one hundred and eighty (180) days immediately following the date of effectiveness or commencement of sales of the offering Effective Date pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: Underwriting Agreement (Bridgeline Digital, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the initial public offering pursuant to which this Warrant is being issuedof the Common Stock, except the transfer of any security:

Appears in 1 contract

Samples: Common Stock Purchase Warrant (Asterias Biotherapeutics, Inc.)

Transferability. Pursuant to FINRA Rule 5110(g)(15110(e), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:: 12

Appears in 1 contract

Samples: Ascent Solar Technologies, Inc.

Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of one 180 days immediately following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:

Appears in 1 contract

Samples: PaxMedica, Inc.

Time is Money Join Law Insider Premium to draft better contracts faster.